By contrast, the Australian Imaging, Biomarkers and Lifestyle (AIBL) study showed that ApoE levels were significantly lower in patients with AD and ApoE levels were significantly lower in ε4 homozygous individuals [29]. The gene discussed is APOE; the disease is Alzheimer disease.